Test-Retest Reproducibility of 18F-AV-1451 Injection for Brain Imaging of Tau in Healthy Volunteers and Cognitively Impaired Subjects.
Phase of Trial: Phase I
Latest Information Update: 18 Jul 2014
Price : $35 *
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease; Cognition disorders
- Focus Diagnostic use
- Sponsors Avid Radiopharmaceuticals
- 31 Aug 2018 Biomarkers information updated
- 06 Jun 2014 Trial status changed from active, no longer recruiting to completed, according to the ClinicalTrials.gov record.
- 03 Apr 2014 Status changed from recruiting to active, no longer recruiting according to the ClinicalTrials.gov record.